Multicentre, Randomised, Double-Blind Study to Compare Stalevo [levodopa/carbidopa/entacapone] to Levodopa/Carbidopa in Patients With Parkinson's Disease Experiencing Symptoms of Early Wearing-Off.
Phase of Trial: Phase IV
Latest Information Update: 09 Nov 2012
At a glance
- Drugs Levodopa/carbidopa; Levodopa/carbidopa/entacapone
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms SEWOP
- Sponsors Orion Pharma
- 31 Aug 2018 Biomarkers information updated
- 17 Jun 2010 Results were reported at the 14th International Congress of Parkinson's Disease and Movement Disorders.
- 23 Jun 2009 Actual patient number (223) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History